These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

308 related items for PubMed ID: 9309087

  • 1. Adjuvant and neoadjuvant chemotherapy for urothelial carcinoma.
    McCaffrey JA, Herr HW.
    Surg Oncol Clin N Am; 1997 Oct; 6(4):667-81. PubMed ID: 9309087
    [Abstract] [Full Text] [Related]

  • 2. Adjuvant chemotherapy for deep muscle-invasive transitional cell bladder carcinoma - a practice guideline.
    Segal R, Winquist E, Lukka H, Chin JL, Brundage M, Markman BR, Cancer Care Ontario Practice Guidelines Initiative Genitourinary Cancer Disease Site Group.
    Can J Urol; 2002 Oct; 9(5):1625-33. PubMed ID: 12431323
    [Abstract] [Full Text] [Related]

  • 3. Perioperative chemotherapy in muscle-invasive bladder cancer to enhance survival and/or as a strategy for bladder preservation.
    Sternberg CN.
    Semin Oncol; 2007 Apr; 34(2):122-8. PubMed ID: 17382795
    [Abstract] [Full Text] [Related]

  • 4. Neoadjuvant chemotherapy for bladder cancer.
    Sonpavde G, Lerner SP.
    Oncology (Williston Park); 2007 Dec; 21(14):1673-81; discussion 1686-8, 1691, 1694. PubMed ID: 18247016
    [Abstract] [Full Text] [Related]

  • 5. Neoadjuvant and adjuvant chemotherapy for invasive bladder cancer.
    Smith MR, Kantoff PW.
    Semin Oncol; 1995 Dec; 22(6):625-32. PubMed ID: 8539637
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effectiveness of adjuvant chemotherapy in transitional cell carcinoma of the urinary bladder with lymph node involvement and/or lymphovascular invasion treated by radical cystectomy.
    Park J, Park S, Song C, Doo C, Cho YM, Ahn H, Kim CS.
    Urology; 2007 Aug; 70(2):257-62. PubMed ID: 17826485
    [Abstract] [Full Text] [Related]

  • 8. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
    Słojewski M.
    Ann Acad Med Stetin; 2000 Aug; 46():217-29. PubMed ID: 11712306
    [Abstract] [Full Text] [Related]

  • 9. [Adjuvant polychemotherapy after radical cystectomy of metastatic bladder cancer].
    Stöckle M.
    Urologe A; 1994 Nov; 33(6):568-75. PubMed ID: 7817458
    [Abstract] [Full Text] [Related]

  • 10. Timing cystectomy and perioperative chemotherapy in the treatment of muscle invasive bladder cancer.
    Izawa JI, Chin JL, Winquist E.
    Can J Urol; 2006 Jun; 13 Suppl 3():48-53. PubMed ID: 16818012
    [Abstract] [Full Text] [Related]

  • 11. The current and future application of adjuvant systemic chemotherapy in patients with bladder cancer following cystectomy.
    Aparicio AM, Elkhouiery AB, Quinn DI.
    Urol Clin North Am; 2005 May; 32(2):217-30, vii. PubMed ID: 15862619
    [Abstract] [Full Text] [Related]

  • 12. Neoadjuvant and adjuvant chemotherapy in muscle-invasive bladder cancer.
    Calabrò F, Sternberg CN.
    Eur Urol; 2009 Feb; 55(2):348-58. PubMed ID: 18977070
    [Abstract] [Full Text] [Related]

  • 13. Improving the prognosis of patients after radical cystectomy. Part II: the role of perioperative chemotherapy.
    Suttmann H, Kamradt J, Lehmann J, Stöckle M.
    BJU Int; 2007 Dec; 100(6):1225-8. PubMed ID: 17979921
    [Abstract] [Full Text] [Related]

  • 14. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium.
    Shariat SF, Karakiewicz PI, Palapattu GS, Lotan Y, Rogers CG, Amiel GE, Vazina A, Gupta A, Bastian PJ, Sagalowsky AI, Schoenberg MP, Lerner SP.
    J Urol; 2006 Dec; 176(6 Pt 1):2414-22; discussion 2422. PubMed ID: 17085118
    [Abstract] [Full Text] [Related]

  • 15. [Prognosis in pT3b infiltrating tumors of the bladder treated by adjuvant chemotherapy].
    Sahwi A, Robert M, Delbos O, Legouffe E, Guiter J, Navratil H.
    Prog Urol; 1998 Dec; 8(6):1007-11. PubMed ID: 9894259
    [Abstract] [Full Text] [Related]

  • 16. The role of chemotherapy in the management of the patient with T3b bladder cancer.
    Millikan R, Dinney CP.
    Semin Urol Oncol; 1996 May; 14(2):81-5. PubMed ID: 8734735
    [Abstract] [Full Text] [Related]

  • 17. Radical cystectomy in the elderly: Comparison of survival between younger and older patients.
    Clark PE, Stein JP, Groshen SG, Cai J, Miranda G, Lieskovsky G, Skinner DG.
    Cancer; 2005 Feb 01; 103(3):546-52. PubMed ID: 15630702
    [Abstract] [Full Text] [Related]

  • 18. The prognostic value of angiogenesis factor expression for predicting recurrence and metastasis of bladder cancer after neoadjuvant chemotherapy and radical cystectomy.
    Inoue K, Slaton JW, Karashima T, Yoshikawa C, Shuin T, Sweeney P, Millikan R, Dinney CP.
    Clin Cancer Res; 2000 Dec 01; 6(12):4866-73. PubMed ID: 11156246
    [Abstract] [Full Text] [Related]

  • 19. Low incidence of perioperative chemotherapy for stage III bladder cancer 1998 to 2003: a report from the National Cancer Data Base.
    David KA, Milowsky MI, Ritchey J, Carroll PR, Nanus DM.
    J Urol; 2007 Aug 01; 178(2):451-4. PubMed ID: 17561135
    [Abstract] [Full Text] [Related]

  • 20. Bladder preservation: optimizing radiotherapy and integrated treatment strategies.
    Mak RH, Zietman AL, Heney NM, Kaufman DS, Shipley WU.
    BJU Int; 2008 Nov 01; 102(9 Pt B):1345-53. PubMed ID: 19035903
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.